Display Settings:

Format

Send to:

Choose Destination
    Med Monatsschr Pharm. 2009 Jul;32(7):263-7.

    [Vitamin C in complementary oncology--update 2009].

    [Article in German]

    Source

    Akademie & Zentrum für Mikronährstoffmedizin, Zweigertstrasse 55, 45130 Essen. uwegroeber@gmx.net

    Abstract

    The antioxidant perhaps most widely used in complementary oncology is vitamin C, particularly by intravenous injection. In light of the recent clinical pharmacokinetic findings, the in vitro evidence of anti-tumour mechanisms and some well-documented cases of advanced cancers the role of high-dose intravenous vitamin C therapy in cancer treatment should be reassessed. High dose intravenous vitamin C therapy may have benefits in patients with advanced cancers, and cancers with poor prognosis and limited therapeutic options, but further clinical studies regarding the safety and efficacy of this therapy are necessary, especially in Germany.

    PMID:
    19731754
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk